Genome Editing Applications in Drug Discovery and Target Validation

Saturday, February 5, 2022

1:00 PM – 4:30 PM

Location: 152

Sam Hasson, PhD

Associate Director
Voyager Therapeutics, Massachusetts, United States
Scott T. Younger, PhD

Director, Disease Gene Engineering
Children’s Mercy Research Institute, Missouri, United States

Additional Fees Apply
-- visit the Short Course Program section for more information.

Genome editing tools such as CRISPR-Cas9 are reshaping what is possible within the biological sciences. This course will introduce the state-of-the-art in genome editing, the current limitations, and the fundamentals of how to apply these technologies to enhance the pursuit of targets and therapeutics.

Who Should Attend:

Assay and HTS biologists

Those interested in drug discovery technology

Scientists working on functional genomics and genetic screens

Those wanting to learn the basics of CRISPR/Cas9 technology and how it can be practically applied

How You Will Benefit From This Course:

Up-to-date information on the tools, methods, and applications of genome editing

Workflows for typical experiments and practical use cases

Case studies of how genome editing is enabling discovery research

Course Topics:

Genome engineering concepts

Gene editing in 2022: Workflows to creating knockouts and knockin cell lines

CRISPR-Cas9 and beyond – tools of the trade

Applications of genome editing in functional genomics

A practical guide to using genome editing tools in genetic screens